研究人员|研究概述
Briscoe博士的研究重点是移植免疫和慢性同种异体抑制进化的基础机制。他已持有几项NIH R01赠款，以支持基于发现的研究，并提高了生物标志物的发展，作为一项关键的变革性护理计划。
研究人员|研究背景
戴维·布里斯科（David Briscoe）博士是哈佛医学院的儿科教授，也是波士顿儿童医院移植的凯西·李球主席。他接受了儿科，肾脏病和移植免疫学的培训，并指导了一项研究计划，重点是对慢性同种异体移植排斥的理解，以实现固体器官移植后增强长期结局的目标。
皇家博士电话获得医学学位College of Surgeons in Ireland and performed his initial residency training in General Medicine and Pediatrics in Dublin. He also completed Pediatric Residency training at the University of Colorado Health Sciences Center in Denver, Colorado, and a postdoctoral fellowship in Pediatric Nephrology at Boston Children’s Hospital and Harvard Medical School. Among several honors, Dr. Briscoe was awarded a Young Investigator Award and the Basic Science Investigator Award of the American Society of Transplantation. He was also elected to the national honors society, the American Society of Clinical Investigation. In 2008, Dr. Briscoe became the Principal Investigator of a T32 training program grant, which he has sustained and is currently funded through 2025.. In 2013, he was appointed Director of the Transplant Research Program at Boston Children’s Hospital, and in 2015, he became the first incumbent Casey Lee Ball Chair in Transplantation.
布里斯科博士担任国家和国际领导职务，包括美国移植学会董事会成员，国际儿科移植协会议员，美国移植国会执行委员会主席，国际移植协会的主席，国际移植协会，国际移植学会委员美国肾脏病学会年度会议的免疫学和美国移植学会公共政策委员会主席。在这些职位上，布里斯科博士一直是小儿移植接受者的强烈拥护者，他最支持基于发现的研究和翻译研究，以影响长期护理。他还是生物医学研究科学家的医生教育和培训的强有力的倡导者。
Briscoe博士在NIH研究部分工作，是特别赠款审查委员会的定期审阅者，以提供移植专业知识。他还曾担任过几种移植期刊的编辑委员会，目前是移植直接的高级编辑。